Zenas Bio rises after over $1M stock purchase by CEO

2026-02-04 10:16:53 ET

More on Zenas BioPharma, Inc.

• Zenas BioPharma, Inc. (ZBIO) Discusses Positive Phase 3 INDIGO Trial Results for Obexelimab in IgG4-Related Disease Transcript
• Zenas: Maintaining 'Strong Buy' As Cross-Trial Comparison Of Obexelimab Should Not Be A Factor
• Zenas Prepares For INDIGO Phase 3 Readout - Reinstating Buy Rating
• Zenas crashes as late-stage trial data for lead asset disappoint
• Best Quant-rated small- and mid-cap healthcare stocks as LLY hits $1T in market cap

Read the full article on Seeking Alpha

For further details see: